Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 10 | 2 | — | — | — | 10 |
Melanoma | D008545 | — | — | 3 | 2 | — | — | — | 3 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 1 | — | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 2 | 1 | — | — | — | 2 |
Colorectal neoplasms | D015179 | — | — | 2 | 1 | — | — | — | 2 |
Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 1 | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Drug common name | PIMASERTIB |
INN | pimasertib |
Description | N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)-4-pyridinecarboxamide is a pyridinecarboxamide. |
Classification | Small molecule |
Drug class | serine/threonine kinase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F |
PDB | — |
CAS-ID | 1204531-26-9 |
RxCUI | — |
ChEMBL ID | CHEMBL2107832 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6ON9RK82AL (ChemIDplus, GSRS) |